ReviewBiophysical reviews2025
Evolution of ribosome X-ray crystallography: from first crystals to atomic resolution.
Review in Biophysical reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
X-ray crystallography has been pivotal in elucidating the structural basis of ribosome function and in informing antibiotic design, from early challenges in purifying and crystallizing these mega-Dalton assemblies to recent advances integrating synchrotron radiation and X-ray free-electron lasers for high-resolution and time-resolved studies. Methodological innovations - including stress-induced lattice packing, extremophile ribosome sources, optimization of the purification procedure and vapor-diffusion screens - have yielded crystals diffracting up to 2.4 Å. Progress in phasing strategies, from multiple isomorphous replacement and multiwavelength anomalous dispersion/single-wavelength anomalous dispersion to cryogenic electron microscopy-guided molecular replacement and serial femtosecond crystallography, has overcome the phase problem for large complexes. Landmark structures of prokaryotic and eukaryotic ribosomes have elucidated the architectural principles underlying peptide bond formation and messenger RNA decoding, leading to inhibitor discovery. Despite the rise of cryogenic electron microscopy, crystallography remains indispensable for mechanistic insights and rational drug design targeting ribosomal sites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.